Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VIAB
Viacom Inc. Class B
VIAB
|
+$109M |
| 2 |
Oracle
ORCL
|
+$107M |
| 3 |
ConocoPhillips
COP
|
+$105M |
| 4 |
Bank of America
BAC
|
+$100M |
| 5 |
Colgate-Palmolive
CL
|
+$93.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$518M |
| 2 |
Intel
INTC
|
+$486M |
| 3 |
IBM
IBM
|
+$306M |
| 4 |
Pfizer
PFE
|
+$286M |
| 5 |
United Parcel Service
UPS
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.53% |
| 2 | Healthcare | 12.29% |
| 3 | Consumer Staples | 10.94% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCLN
2251
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $592K | ﹤0.01% |
85,900
-235,426
| -73% | -$1.41M |
|
2252
NRC Health Common Stock
NRC
$456M
| $589K | ﹤0.01% |
45,300
-3,500
| -7% | -$48.1K |
|
|
CTLP
2253
DELISTED
Cantaloupe
CTLP
| $588K | ﹤0.01% |
326,915
+33,800
| +12% | +$67K |
|
|
EXAC
2254
DELISTED
Exactech Inc
EXAC
| $586K | ﹤0.01% |
25,600
+619
| +2% | +$14.7K |
|
|
JNP
2255
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $583K | ﹤0.01% |
98,950
+4,200
| +4% | +$25.6K |
|
2256
Fortuna Silver Mines
FSM
$3.21B
| $581K | ﹤0.01% |
143,200
+121,800
| +569% | +$623K |
|
2257
LCNB Corp
LCNB
$281M
| $581K | ﹤0.01% |
38,700
-17,300
| -31% | -$268K |
|
|
PSTB
2258
DELISTED
Park Sterling Corp.
PSTB
| $580K | ﹤0.01% |
87,423
-16,670
| -16% | -$113K |
|
2259
Dorchester Minerals
DMLP
$1.35B
| $577K | ﹤0.01% |
19,500
-33,540
| -63% | -$1.09M |
|
|
ZGNX
2260
DELISTED
Zogenix, Inc.
ZGNX
| $576K | ﹤0.01% |
+62,660
| New | +$713K |
|
|
INFI
2261
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $574K | ﹤0.01% |
42,800
-155,800
| -78% | -$1.86M |
|
2262
PAR Technology
PAR
$741M
| $573K | ﹤0.01% |
116,900
+7,900
| +7% | +$34.1K |
|
2263
Verastem
VSTM
$629M
| $565K | ﹤0.01% |
+5,525
| New | +$580K |
|
|
POZN
2264
DELISTED
POZEN INC
POZN
| $564K | ﹤0.01% |
76,800
-1,519
| -2% | -$12.2K |
|
2265
RLI Corp
RLI
$5.78B
| $563K | ﹤0.01% |
+26,000
| New | +$580K |
|
2266
China Yuchai International
CYD
$1.76B
| $560K | ﹤0.01% |
30,185
+10,771
| +55% | +$220K |
|
|
VRML
2267
DELISTED
Vermillion, Inc.
VRML
| $560K | ﹤0.01% |
312,600
+11,100
| +4% | +$24.8K |
|
|
NBBC
2268
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
| $559K | ﹤0.01% |
73,700
+21,700
| +42% | +$165K |
|
|
SKH
2269
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
| $558K | ﹤0.01% |
84,500
+12,400
| +17% | +$81.3K |
|
2270
ITT
ITT
$19.4B
| $557K | ﹤0.01% |
12,400
-370,700
| -97% | -$17.6M |
|
|
WILN
2271
DELISTED
Wi-LAN Inc.
WILN
| $555K | ﹤0.01% |
154,100
+101,500
| +193% | +$353K |
|
|
CBNJ
2272
DELISTED
CAPE BANCORP, INC COM
CBNJ
| $555K | ﹤0.01% |
58,897
+5,107
| +9% | +$51.7K |
|
2273
Performance Shipping
PSHG
$21.8M
| – | – |
0
| – | – |
|
2274
Danaos Corp
DAC
$2.55B
| $553K | ﹤0.01% |
7,686
+336
| +5% | +$27K |
|
2275
EyePoint Inc
EYPT
$1.17B
| $553K | ﹤0.01% |
+12,510
| New | +$564K |
|
Similar funds
Jim Simons's Q3 2014 Portfolio in Review
As of Q3 2014, Jim Simons held 3,213 positions worth $36.5B, down 15% from $42.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons withdrew a net $5.32B in Q3 2014, closing 459 positions and reducing 1,053 holdings. Its most notable exit was Apple, an estimated $518M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Jim Simons opened a new position in Viacom Inc. Class B worth $102M.
- Jim Simons's largest Q3 2014 buy was Viacom Inc. Class B: 1,327,500 shares worth $102M.
- Jim Simons added most to ConocoPhillips in Q3 2014, an estimated $105M increase.
- Jim Simons's biggest Q3 2014 reduction was Intel, cutting an estimated $486M.
- Jim Simons fully exited Apple in Q3 2014, selling an estimated $518M.
- Jim Simons's ten largest holdings make up 13% of its $36.5B portfolio in Q3 2014.
- Jim Simons opened 460 new positions and closed 459 in Q3 2014.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $36.5B.
Based on Renaissance Technologies's 13F filing for Q3 2014, filed 12 Nov 2014.